Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 103

1.

Effectiveness of three types of rapid tests for the detection of hepatitis C virus antibodies among blood donors in Alexandria, Egypt.

Al-Tahish G, El-Barrawy MA, Hashish MH, Heddaya Z.

J Virol Methods. 2013 May;189(2):370-4. doi: 10.1016/j.jviromet.2013.03.013. Epub 2013 Mar 27.

PMID:
23541785
2.
3.
4.

Evaluation of the available anti-HCV antibody detection tests and RT-PCR assay in the diagnosis of hepatitis C virus infection.

Tashkandy MA, Khodari YA, Ibrahim AM, Dhafar KO, Gazzaz ZJ, Azab BA.

Saudi J Kidney Dis Transpl. 2007 Nov;18(4):523-31.

5.

Comparison of two second-generation anti-hepatitis C virus ELISA on 21431 US blood donor samples.

Anderson SC, Hathaway T, Kuramoto IK, Holland PV, Gilcher R, Koch T, Hojvat S.

J Viral Hepat. 1995;2(1):55-61.

PMID:
7493295
6.

Performance of three generations of anti-hepatitis C virus enzyme-linked immunosorbent assays in donors and patients.

Vrielink H, Reesink HW, van den Burg PJ, Zaaijer HL, Cuypers HT, Lelie PN, van der Poel CL.

Transfusion. 1997 Aug;37(8):845-9.

PMID:
9280331
7.

Prevalence of antibodies to hepatitis C virus in populations at low and high risk for sexually transmitted diseases in Rio de Janeiro.

Edelenyi-Pinto M, Carvalho AP, Nogueira C, Ferreira Júnior O, Schechter M.

Mem Inst Oswaldo Cruz. 1993 Apr-Jun;88(2):305-7.

8.
10.

Evaluation of third generation anti-HCV enzyme immunoassays.

Panigrahi AK, Nayak B, Dixit R, Acharya SK, Panda SK.

Trop Gastroenterol. 1998 Jul-Sep;19(3):105-7.

PMID:
9828708
11.

Hepatitis C virus RNA in blood donor sera detected by the polymerase chain reaction: comparison with supplementary hepatitis C antibody assays.

Widell A, Månsson AS, Sundström G, Hansson BG, Nordenfelt E.

J Med Virol. 1991 Dec;35(4):253-8.

PMID:
1724983
12.
13.

Significance of the signal-to-cutoff ratios of anti-hepatitis C virus enzyme immunoassays in screening of Chinese blood donors.

Ren FR, Lv QS, Zhuang H, Li JJ, Gong XY, Gao GJ, Liu CL, Wang JX, Yao FZ, Zheng YR, Zhu FM, Tiemuer MH, Bai XH, Shan H.

Transfusion. 2005 Nov;45(11):1816-22. Erratum in: Transfusion. 2006 Jan;46(1):163.

PMID:
16271110
14.
15.

Rapid immunoassay alone is insufficient for the detection of hepatitis C virus infection among high-risk population.

Firdaus R, Saha K, Sadhukhan PC.

J Viral Hepat. 2013 Apr;20(4):290-3. doi: 10.1111/jvh.12002. Epub 2012 Aug 27.

PMID:
23490374
16.
17.

Diverse patterns of recognition of hepatitis C virus core and nonstructural antigens by antibodies present in Egyptian cancer patients and blood donors.

Attia MA, Zekri AR, Goudsmit J, Boom R, Khaled HM, Mansour MT, de Wolf F, el-Din HM, Sol CJ.

J Clin Microbiol. 1996 Nov;34(11):2665-9.

18.

Evaluation of newly developed microparticle enzyme immunoassays for the detection of HCV antibodies.

Hennig H, Schlenke P, Kirchner H, Bauer I, Schulte-Kellinghaus B, Bludau H.

J Virol Methods. 2000 Feb;84(2):181-90.

PMID:
10680968
19.
20.

Prevalence of hepatitis C virus and genotype distribution in an Australian volunteer blood donor population.

Mison LM, Young IF, O'Donoghue M, Cowley N, Thorlton N, Hyland CA.

Transfusion. 1997 Jan;37(1):73-8.

PMID:
9024493

Supplemental Content

Support Center